Another interesting nugget - "During Q1,Acadia conducted pre-NDA meetings with the FDA to discuss the clinical data package and thechemistry, manufacturing and controls package that will be included in the NDA."
The timeline for NDA submission (June) which will deliver Neuren $14m on acceptance has not been adjusted so presumably these meetings went well.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-5
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$13.10 |
Change
-0.800(5.76%) |
Mkt cap ! $1.629B | |||
| Open | High | Low | Value | Volume |
| $13.95 | $13.96 | $12.88 | $9.534M | 725.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 266 | $13.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.15 | 1619 | 2 |
View Market Depth
| Last trade - 16.10pm 13/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |